Europeans are Interested in Online Patient Education Programs
Half of Europeans using the Internet for health information are interested in online patient education programs from pharmaceutical companies, although just a small fraction are currently using these types of programs, according to Manhattan Research's Cybercitizen Health® Europe v10.0 research. The survey explored the digital media and online health behaviors of 3,000 online adults in France, Germany, Italy, Spain, and the United Kingdom.
Read more ...
Philippe Tsvetkov et al. present new perspective on Alzheimer's disease drug development
A team of researchers (Philippe Tsvetkov et al.) from Engelhardt Institute of Molecular Biology (Moscow, Russia) have shed light on molecular mechanisms of Alzheimer's disease with perspective on development of novel drug therapies. The study, published in Biophysical Journal, provides insights into molecular mechanisms of Zinc-induced aggregation of amyloid-β peptide.
Read more ...
Multidrug resistant bacteria remain a public health issue in Europe
On the occasion of the European Antibiotic Awareness Day, ECDC is releasing new European-wide surveillance data on antibiotic resistance from the European Antimicrobial Resistance Surveillance Network (EARS-Net). With annually up to 400,000 patients [1]reported to suffer from infections resistant to multiple antibiotics, the data show that antibiotic resistance remains a public health problem across the European Union.
Read more ...
Millions unite for diabetes awareness on World Diabetes Day 2010
Starting today, people from all corners of the world are uniting together for three days of celebration to put diabetes firmly in the public spotlight. World Diabetes Day is the best opportunity there is to draw attention to the silent killer that is diabetes. Celebrated every year on 14 November, World Diabetes Day was initiated in 1991 by the International Diabetes Federation (IDF) and the World Health Organization in response to growing concerns about the escalating health threat that diabetes poses to the global community.
Read more ...
Alzheimer's-linked protein can travel into brain
Researchers have discovered that tissue from outside the brain that contains misfolded beta-amyloid protein can travel and 'infect' the brain. Pathological protein deposits have been strongly linked to the genesis of the neurodegenerative disorder called Alzheimer's disease. The support for the research came from the ERA-NET NEURON (Network of European Funding for Neuroscience Research) project, which backed the MIPROTRAN project involved in the study. ERA-NET NEURON, for its part, received nearly EUR 3 million under the ERA-NET scheme of the Sixth Framework Programme (FP6).
Read more ...
Scientists say new gene variant can cut hypertension risk
People with hypertension take heart: EU-funded scientists have discovered a new gene variant that could lead to better prevention and treatment measures to fight high blood pressure. The research, published in the journal PLoS Genetics, is funded in part by the INGENIOUS HYPERCARE (Integrated genomics, clinical research and care in hypertension) project, which clinched EUR 10 million under the 'Life sciences, genomics and biotechnology for health') Thematic area of the EU's Sixth Framework Programme (FP6).
Read more ...
Nanohale AG and Rostechnologies Sign Memorandum to Set up Joint Venture
Within the framework of an international collaboration in the area of innovative technology, Nanohale AG and the Russian state-owned holding company Rostechnologii signed a
memorandum of understanding regarding future collaboration. The memorandum of understanding envisions the formation of a joint venture in which Nanohale AG would hold a 50 percent interest.
Read more ...